In addition, the feasibility of intravenous administration of 300 mg NMN suggests that NAMPT may be activated and TG levels may be suppressed, which may help improve obesity and prevent aging. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.